Patients with previously untreated symptomatic chronic lymphocytic leukemia. research hub

Study PACIFIC: Fixed duration treatment with combined pirtobrutinib and short course immuno-chemotherapy in fit patients with previously untreated symptomatic chronic lymphocytic leukemia (CLL). A phase II FILO trial

This study looks at a new drug, pirtobrutinib, combined with standard treatment for people with chronic lymphocytic leukaemia (CLL) who haven't had treatment before. Researchers want to see if this combination can get rid of the leukaemia cells effectively and for how long, aiming for a fixed treatment period.